Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
15 août 2023 08h30 HE
|
Qualigen Therapeutics, Inc.
Investigational New Drug (IND) clearance transitions Qualigen from preclinical to clinical-stage company Company divests FastPack® diagnostics business for approximately $5 million in all cash...
Vinco Ventures, Inc. Reports Financial Results for the Year and Fourth Quarter Ended December 31, 2021
18 avr. 2022 07h00 HE
|
Vinco Ventures, Inc.
Fairport, NY, April 18, 2022 (GLOBE NEWSWIRE) -- Vinco Ventures, Inc. (NASDAQ:BBIG), a digital media and content technologies holding company (“Vinco Ventures,” “Vinco,” or the “Company”), today...
Vinco Ventures, Inc. Reports Financial Results for the Year Ended December 31, 2020
09 avr. 2021 08h36 HE
|
Vinco Ventures, Inc.
Bethlehem, P.A., April 09, 2021 (GLOBE NEWSWIRE) -- Vinco Ventures (f/k/a Edison Nation, Inc.) (NASDAQ:BBIG), a digital media merger and acquisitions company, today announced results for the year...
ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2020
11 août 2020 08h47 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Aug. 11, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced net sales of $3.6 million for the three months ended June 30,...
ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2020
12 mai 2020 08h00 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, May 12, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced net sales of $1.9 million for the three months ended March 31,...
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2019
12 nov. 2019 09h35 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 12, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.8 million for the three months ended...
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
09 nov. 2018 07h00 HE
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the...